Concepedia

JHM Schellens

JS

13

Publications

583

Citations

12

H-Index

1994

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Slotervaartziekenhuis

The Netherlands Cancer Institute

Erasmus MC Cancer Institute

Utrecht University

JHM Schellens is an author at Rotterdam University of Applied Sciences specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1994–2012

13

Publications

13

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

JHM Schellens, Jun Ma, A.S.T. Planting et al. · British Journal of Cancer · 1996 · 146 citations · Full text

, , +9

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor

JHM Schellens, G.J. Creemers, Hilde Rosing et al. · British Journal of Cancer · 1996 · 130 citations · Full text

, , +5

Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line

Jun Ma, Marc Maliepaard, Kees Nooter et al. · British Journal of Cancer · 1998 · 62 citations

, , +7

Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration

CJH Gerrits, G.J. Creemers, JHM Schellens et al. · British Journal of Cancer · 1996 · 45 citations · Full text

, , +6

Pharmacokinetic-dynamic relationship of cisplatin in vitro: simulation of an i.v. bolus and 3 h and 20 h infusion

Jun Ma, Jaap Verweij, H. J. Kolker et al. · British Journal of Cancer · 1994 · 34 citations · Full text

, , +6

Rows per page

1–5 of 13